Heme oxygenase-1 gene therapy: a novel immunomodulatory approach in liver allograft recipients?
Ke
B
B
Dumont-UCLA Transplant Center, University of California, Los Angeles, California, USA.
Shen
X D
XD
Melinek
J
J
Gao
F
F
Ritter
T
T
Volk
H D
HD
Busuttil
R W
RW
Kupiec-Weglinski
J W
JW
D000208:Acute Disease; D000818:Animals; D015316:Genetic Therapy / Q000379:methods*; D006084:Graft Rejection / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D006419:Heme Oxygenase (Decyclizing) / Q000235:genetics* / Q000378:metabolism; D051547:Heme Oxygenase-1; D007371:Interferon-gamma / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous; D001616:beta-Galactosidase / Q000235:genetics / Q000378:metabolism
D007376:Interleukin-2; D007371:Interferon-gamma; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; D001616:beta-Galactosidase